1. Introduction {#sec0005}
===============

A solid pseudopapillary neoplasm (SPN) of the pancreas is rare pancreatic tumor and occurs predominantly in young women [@bib0005], [@bib0010]. The clinical presentation of SPNs is nonspecific, but acute pancreatitis is rare in the reported literature. Herein, we report a man with a small SPN of the pancreas who presented with acute pancreatitis and mimicking pancreatic cancer.

2. Presentation of case {#sec0010}
=======================

A 36-year-old man was referred to our hospital because of upper abdominal pain and elevation of serum amylase. His medical history was unremarkable except for a duodenal ulcer. He was a moderate drinker but had no history of acute pancreatitis. Laboratory data on admission showed elevated serum levels of pancreatic enzymes: amylase, 1600 IU/L (normal range, 40--129IU/L); *p*-amylase, 1541 IU/L (18--55 IU/L); and lipase, 2243 IU/L (17--57 IU/L). Serum levels of the tumor markers carcinoembryonic antigen and carbohydrate antigen 19-9 were within normal ranges. A contrast-enhanced computed tomography (CT) scan showed diffuse enlargement of the pancreas with inflammatory change in *peri*-pancreatic fatty tissue and a poorly enhanced and indistinct nodule in the pancreas body. The distal side of the main pancreatic duct (MPD) was dilated ([Fig. 1](#fig0005){ref-type="fig"}**a** and **b**). He was admitted with a diagnosis of acute pancreatitis. The pancreatitis was improved with conservative treatment and he was discharged three weeks later. However, acute pancreatitis recurred twice during a period of two months with repeated admission and discharge. The mass in the pancreas body gradually became clearer, and a mass of 10 mm in diameter was detected 53 days later by CT ([Fig. 1](#fig0005){ref-type="fig"}**c**). The mass contained no calcification or cystic lesion. The mass showed low signal intensity on T2-weighted images and diffusion-weighted images obtained by magnetic resonance imaging (MRI) ([Fig. 1](#fig0005){ref-type="fig"}**d**). Magnetic resonance cholangiopancreatography (MRCP) showed stenosis of the MPD adjacent to the mass ([Fig. 2](#fig0010){ref-type="fig"}**a**). Endoscopic retrograde cholangiopancreatography (ERCP) also showed stenosis of the MPD ([Fig. 2](#fig0010){ref-type="fig"}**b**). Cytology of pancreatic juice collected during the ERCP did not reveal malignant cells ([Fig. 2](#fig0010){ref-type="fig"}**c**). Although a definitive diagnosis could not be made, the recurrent acute pancreatitis was thought to be related to the stenosis of the MPD caused by the mass in the pancreas body. Furthermore, the possibility of a malignant disease such as pancreatic cancer for the mass could not be excluded from the radiological findings. Distal pancreatectomy with regional lymph node dissection was performed. Macroscopically, a well-circumscribed mass, measuring 12 mm, in the pancreas body was observed ([Fig. 3](#fig0015){ref-type="fig"}**a** and **b**). Microscopically, most of the mass consisted of a fibrous nodule, but an irregularly arranged pseudopapillary structure composed of fairly uniform tumor cells was seen around the fibrous nodule. The tumor cells had proliferated invasively in the pancreatic parenchyma ([Fig. 3](#fig0015){ref-type="fig"}**c** and **d**). The tumor located adjacent to the MPD and the fibrous and degenerative change had caused a deformity of the wall of the MPD ([Fig. 3](#fig0015){ref-type="fig"}**e**). The border region between the fibrous nodule and the tumor contained calcification, old hemorrhage and cholesterin crystals ([Fig. 3](#fig0015){ref-type="fig"}**f**). Immunohistochemically, the tumor was positive for ß-catenin, vimentin, CD10, synaptophysin (Syn) ([Fig. 4](#fig0020){ref-type="fig"}**a**--**d**), CD56, and neuron-specific enolase (NSE), but negative for chromogranin (CgA) ([Fig. 4](#fig0020){ref-type="fig"}**e**) and insulin. The Ki67 labeling index was approximately 3% ([Fig. 4](#fig0020){ref-type="fig"}**f**). Based on these findings, a diagnosis of SPN of the pancreas was made. Lymph node metastasis was not found. The patient's postoperative course was uneventful and he was discharged on the 22nd day after the operation. At a 32-month follow-up after resection, the patient did not have any recurrence of SPN or pancreatitis.

3. Discussion {#sec0015}
=============

SPN of the pancreas is a rare neoplasm accounting for only about 0.13--2.7% of all pancreatic tumors [@bib0005]. SPN is regarded as a low-grade malignant potential tumor with an excellent prognosis after complete resection. In a large review of the English literature including 718 patients with SPN [@bib0010], the male-to-female ratio was 1:9.78 with a median age of 21.97 years and the mean diameter of the tumors was 6.08 cm. The clinical presentation is nonspecific. The majority of patients presented with abdominal pain, abdominal mass or fullness, but gastrointestinal obstruction, anemia, pancreatitis [@bib0015], bile duct obstruction, or traumatic rupture with hemoperitoneum [@bib0020] was less frequently noted. On the basis of the review, typical SPN occurs predominantly in young females and the tumor is usually large and is accompanied by nonspecific abdominal complaints.　The current case is not typical in some aspects compared with typical SPNs. First, the tumor developed in a middle-aged man. Second, the tumor was quite small and mimicked a malignant pancreatic tumor. Third, the first clinical presentation was acute pancreatitis.

Male patients with SPN have accounted for less than 10% of the patients. SPN shows a clear female predilection with very few reported cases in male patients [@bib0010]. Several reports suggested that sex hormones play a role in the pathogenesis or growth of SPN [@bib0025]. Machado et al. examined clinical differences between male and female patients. The mean age of male patients was higher than that of female patients. Although tumor size, location and symptoms were the same, tumor aggressiveness such as portal vein invasion and/or development of metastases was more frequent in male patients. They concluded that SPN in male patients has delayed onset and aggressiveness compared with female patients [@bib0030].

The typical CT imaging features of SPNs are a large well-encapsulated mass with varying solid and cystic components caused by hemorrhagic degeneration. However, diagnosis can be difficult, especially for in small tumors. Baek et al. reported that SPNs of less than 3 cm in diameter were purely solid lesions and lacked a cystic component [@bib0035]. Furthermore, 75% of small SPNs lacked any type of calcification. Consequently, small atypical SPNs have been frequently misdiagnosed as pancreatic cancer [@bib0035]. Because of its distinctive biological characteristics and prognosis, SPN should be distinguished from other pancreatic cancers.

Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) has been reported to be a useful diagnostic tool for pancreatic tumors [@bib0040]. Preoperative diagnosis of SPN is made in 75% of cases on the basis of EUS-FNA cytology [@bib0045]. However, seeding of the needle tract by cancer cells and complications such as bleeding, pancreatic fistula and biliary fistula during the procedure have been reported [@bib0050]. FNA should be performed only for cases in which radiological diagnosis is not clear.

In our case, the tumor was small and lacked a cystic component and calcification on CT imaging. Additionally, the MPD showed stenosis adjacent to the tumor. Due to these atypical images, it was difficult to make a speculation about SPN. This case might have been a good indication for EUS-FNA, but the tumor was difficult to detect by EUS and EUS-FNA was not performed. Because the tumor seemed to cause the recurrent acute pancreatitis and the possibility of a malignant pancreatic tumor could not be excluded, distal pancreatectomy with regional lymph node dissection was performed.

To examine the rarity of SPNs with acute pancreatitis, we performed searches of the PubMed database and Japan Medical Abstracts Society using the following keywords: (acute pancreatitis) and (SPN). To the best our knowledge; only 6 cases including the current case have been reported in the literature ([Table 1](#tbl0005){ref-type="table"}) [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075]. Four patients were female and two were male. The mean age was 30.3 years and the mean size of tumors was 5.15 cm. All of the tumors were located in the pancreas body or tail. MPD imaging was described for four cases: obstruction in one case; narrowing (or stenosis) and dilatation in two cases and compression in one case. Despite the large size of the mass; MPD stenosis or dilatation has been reported to be rare in SPN. Generally; stenosis or dilatation of the MPD is useful for differentiating SPNs from malignant pancreatic tumors [@bib0035]; but we should be aware that MPD stenosis or dilatation is seen also in SPNs. The operative procedures were distal pancreatectomy in five cases and tumor enucleation in one case. After complete resection of the tumor; postoperative courses of all but one of the cases were uneventful with no recurrence of SPN or acute pancreatitis. There is no doubt that the recurrent acute pancreatitis in our case was related to the stenosis of the MPD caused by the SPN. The question arises as to why the SPN induced acute pancreatitis because SPN of the pancreas is considered to be a slow-growing neoplasm [@bib0080]. The exact mechanism of acute pancreatitis is still unclear; but Sakagami et al. hypothesized that non-traumatic internal bleeding may lead to rapid tumor expansion; which results in acute pancreatitis triggered by ischemia; distension or duct obstruction [@bib0060]. In our case; we speculate that the fibrous and degenerative change around the tumor located adjacent to the MPD induced a deformity in the wall of the MPD. This change might have induced stenosis of the MPD and acute pancreatitis.

4. Conclusion {#sec0020}
=============

We report a man with a small SPN of the pancreas presenting with acute pancreatitis and mimicking pancreatic cancer. We should be aware that this rare pancreatic tumor can become a cause of acute pancreatitis.
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![(**a**) Contrast-enhanced computed tomography (CT) scan showed a poorly enhanced and indistinct nodule in the pancreas body (white arrowhead). (**b**) The distal side of the main pancreatic duct (MPD) was dilated (white arrow). (**c**) The mass in the pancreas body was 10 mm in diameter 53 days later (yellow arrowhead). (**d**) The mass showed low signal intensity on T2-weighted images obtained by magnetic resonance imaging (MRI) (red arrowhead).](gr1){#fig0005}

![(**a**) Magnetic resonance cholangiopancreatography (MRCP) showed stenosis of the MPD adjacent to the mass (white arrowhead). (**b**) Endoscopic retrograde cholangiopancreatography (ERCP) also showed stenosis of the MPD (yellow arrowhead). (**c**) Cytology of pancreatic juice did not reveal malignant cells.](gr2){#fig0010}

![(**a**) Macroscopically, a well-circumscribed mass in the pancreas body was observed (white arrows). (**c**, **d**) Magnified view of the black frame area in (**b**). The tumor cells had proliferated invasively in the pancreatic parenchyma (black arrowhead). An irregularly arranged pseudopapillary structure composed of fairly uniform tumor cells was seen around the fibrous nodule. (**e**) Magnified view of the yellow frame area in (**b**). Fibrous and degenerative change induced a deformity of the wall of the MPD (asterisk indicating MPD). (**f)** The border region between the fibrous nodule and the tumor contained calcification, old hemorrhage and cholesterin crystals.](gr3){#fig0015}

![Immunohistochemically, the tumor was positive for ß-catenin (**a**), vimentin (**b**), CD10 (**c)**, and synaptophysin (Syn) (**d**) but negative for chromogranin (CgA) (**e)**. The Ki67 labeling index was approximately 3% (**f**).](gr4){#fig0020}

###### 

Reported cases of SPN presenting with acute pancreatitis.

Table 1

  --------------------------------------------------------------------------------------------------------------------------------------
                  Case 1 \[11\]                 Case 2 \[12\]   Case 3 \[13\]    Case 4 \[14\]   Case 5 \[15\]   Our case
  --------------- ----------------------------- --------------- ---------------- --------------- --------------- -----------------------
  Age             27                            21              31               12              55              36

  Gender          Female                        Female          Female           Female          Male            Male

  Location        Tail                          Tail            Body             Tail            Body            Body

  Size (cm)       3.2                           8.0             5.0              8.0             5.5             1.2

  MPD imaging     Obstruction                   n.d             Narrowing\       n.d             Compression     Stenosis
                                                                and dilatation                                   

  Preoperative\   s/o Cystic pancreatic tumor   n.d             s/o SPN          n.d             SPN\            s/o Pancreatic cancer
  diagnosis                                                                                      (EUS-FNA)       

  Operation       DP                            DP              DP               Enucleation     DP              DP

  Prognosis       2 yrs\                        3.5 yrs\        2 yrs\           n.d             6 mo\           2.5 yrs\
                  no recurrence                 no recurrence   no recurrence                    no recurrence   no recurrence
  --------------------------------------------------------------------------------------------------------------------------------------

*MPD,* main pancreatic duct; *DP,* distal pancreatectomy; *SPN,* solid pseudopapillary neoplasm; *s/o,* suspected of; *EUS-FNA*, endoscopic ultrasonography guided fine-needle aspiration; *n.d,* not described.
